https://www.selleckchem.com/pr....oducts/emricasan-idn
Based on the pathophysiology, several immunotherapies have been tried in RE (none exhaustively corticosteroid, intravenous immunoglobulins, tacrolimus, azathioprine, adalimumab, mycophenolate mofetil, natalizumab). However, only small cohorts have been reported without comparative study. In this review, we will summarise some pathophysiological mechanisms of RE, before reporting the literature data concerning immunotherapies. We then discuss the limitations of these studies and the prospects for further research.
Me gusta
Comentario
Compartir
